What dose-fractionation do you utilize when treating at-risk and elective lymph node levels in patients with HPV-positive oropharyngeal squamous cell carcinoma?
Do you reduce the dose in such cases? Do you treat with six fractions per week similar to RTOG 1016 (w/ or without chemo)?